Dara Azar

Stock Analyst at Stifel

(2.43)

# 2,503

Out of 5,237 analysts

2

Total ratings

50%

Success rate

46.04%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dara Azar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SMMT Summit Therapeutics	Initiates: Buy	$45	$18.66	+141.16%	1	Apr 8, 2026
	INBX Inhibrx Biosciences	Initiates: Buy	$150	$127.58	+17.57%	1	Apr 8, 2026

Summit Therapeutics

Apr 8, 2026

Initiates: Buy

Price Target: $45

Current: $18.66

Upside: +141.16%

Inhibrx Biosciences

Apr 8, 2026

Initiates: Buy

Price Target: $150

Current: $127.58

Upside: +17.57%